VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 366 filers reported holding VALEANT PHARMACEUTICALS INTL in Q3 2013. The put-call ratio across all filers is 0.62 and the average weighting 1.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2015 | $1,428,000 | +543.2% | 8,000 | +700.0% | 0.09% | +760.0% |
| Q2 2015 | $222,000 | -95.8% | 1,000 | -97.3% | 0.01% | -96.5% |
| Q4 2014 | $5,329,000 | -36.5% | 37,240 | -41.8% | 0.28% | -34.5% |
| Q3 2014 | $8,397,000 | +56.7% | 64,000 | +50.6% | 0.43% | +51.6% |
| Q2 2014 | $5,360,000 | -25.0% | 42,500 | -21.6% | 0.28% | -9.5% |
| Q1 2014 | $7,148,000 | -78.6% | 54,223 | -80.9% | 0.32% | -77.7% |
| Q4 2013 | $33,383,000 | -2.9% | 284,352 | -13.7% | 1.41% | -3.2% |
| Q3 2013 | $34,377,000 | -21.7% | 329,498 | -35.4% | 1.46% | -37.5% |
| Q2 2013 | $43,918,000 | – | 510,203 | – | 2.33% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Chou Associates Management | 1,648,992 | $38,323,000 | 14.52% |
| Paulson & Co. | 20,839,035 | $484,299,000 | 9.89% |
| MILLER VALUE PARTNERS, LLC | 4,999,064 | $116,178,000 | 4.34% |
| GoldenTree Asset Management | 1,140,205 | $26,498,000 | 4.21% |
| Pomelo Capital LLC | 1,760,000 | $40,902,000 | 4.00% |
| Bruce & Co., Inc. | 860,000 | $19,986,000 | 3.98% |
| ValueAct Holdings | 18,033,149 | $419,090,000 | 3.79% |
| Stanley Capital Management, LLC | 318,400 | $7,400,000 | 3.25% |
| Kazazian Asset Management, LLC | 134,784 | $3,132,000 | 2.87% |
| Phoenix Investment Adviser LLC | 58,400 | $1,357,000 | 2.48% |